| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2573969A1 Oxidative degradation products of atorvastatin calcium |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | CA2572753A1 Novel o-aminophenol derivatives and colorants containing said compounds |
| 01/25/2006 | EP1619182A1 Substance exhibiting antidepressant property |
| 01/25/2006 | EP1618089A1 Method of preparing a ring compound having two adjacent chiral centers |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | CN1726212A Pre-organized tricyclic integrase inhibitor compounds |
| 01/25/2006 | CN1726200A Ionic liquids comprising [N(CF3)2] anions |
| 01/25/2006 | CN1724518A Preparation method of N-substituted imide |
| 01/24/2006 | USRE38947 Method of enantioselectively catalyzing a reaction |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/24/2006 | US6989263 Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| 01/24/2006 | US6989139 Matrix metalloproteinase inhibitors |
| 01/24/2006 | US6988431 Removal tool for locking nut, bolt and clip systems and assemblies |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/19/2006 | WO2006005551A1 Substituted 2-pyrrolidone derivatives as fungicides and insecticides |
| 01/19/2006 | WO2005102996A3 A process for the preparation of 2,2-disubstituted pyrroles |
| 01/19/2006 | WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014821 Inhibitors of SARS 3C like protease |
| 01/19/2006 | US20060014794 CXCR1 and CXCR2 chemokine antagonists |
| 01/19/2006 | US20060014783 Sulfonylamino-acetic acid derivatives |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/19/2006 | US20060014735 immunoglobulins; affinity chromatography |
| 01/19/2006 | US20060014665 Therapeutic agent |
| 01/19/2006 | DE102004030753A1 3'-Alkoxy spirocyclische Tetram- und Tretronsäuren 3'-alkoxy spirocyclic tetramic and Tretronsäuren |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1615884A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 01/18/2006 | EP1615883A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 01/18/2006 | EP1615882A2 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1255733B1 Farnesyl transferase inhibitors |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723194A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/18/2006 | CN1721498A Fluorescent maleimides and uses thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721404A Flame retardant resin blends based on polymers |
| 01/18/2006 | CN1721403A Water soluble bilirubin and its synthesis process and use |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/17/2006 | US6987192 Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 01/17/2006 | US6987191 amination of gamma butyrolactone in a continuous liquid phase, recycling unreacted effluents with ammonia and methanol to obtain mixed methylamines. |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | US6987084 Photo-labile pro-fragrance conjugates |
| 01/17/2006 | US6986833 For the preparation of dimethylpropylamine from dimethylamine and propionaldehyde in the presence of hydrogen |
| 01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | US20060009651 Benzophenones as inhibitors of reverse transcriptase |
| 01/12/2006 | US20060009646 Novel organic molecular catalyst having binaphthol skeketon and processes for producing the same and application thereof |
| 01/12/2006 | US20060009626 Amidation or condensation of 2-aryl-3-alkoxycarbonyl-4-phenylhydrazone-5-pyrrolinones with a diamine or diol; paints |
| 01/12/2006 | US20060009507 LPA receptor agonists and antagonists and methods of use |
| 01/12/2006 | US20060009487 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060009416 Vitamin B6, pyridinoline, 3-hydroxypyridine, or an N-alkyl-3-hydroxypyridine; sunscreen agents |
| 01/12/2006 | US20060009394 alkylating a 4-protected hydroxyl pyroglutamic acid derivative with an alkylating agent to prepare a 4-protected hydroxyl-4-alkylglutamic acid derivative, followed by the steps of hydrolysis and deprotection |
| 01/12/2006 | DE102004029811A1 Verfahren zur Herstellung von Alkenen durch Eliminierung von Wasser aus Alkoholen mit Alkylphosphonsäureanhydriden Process for the preparation of alkenes by elimination of water from alcohols having alkylphosphonic |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 01/11/2006 | EP1613762A2 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 01/11/2006 | EP1613635A2 Solid phase synthesis of antitumoral compounds |
| 01/11/2006 | EP1613590A2 4-(3,4-disubstituted phenyl)-pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 01/11/2006 | EP1613586A1 Process for producing amino acid derivatives |
| 01/11/2006 | EP1613573A2 Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid |
| 01/11/2006 | EP1613304A1 Dpp-iv inhibitors |
| 01/11/2006 | EP1338596B1 processes for the preparation of carbapenem-type antibacterial agents |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | CN1720245A Oxime ester photoinitiators with heteroaromatic groups |
| 01/11/2006 | CN1720242A Synthetic lactone formulations and method of use |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984736 comprises optionally supported raney catalysts; for production of cleaning compositions |
| 01/10/2006 | US6984658 Oligo/polysuccinimides, process for producing thereof and their use |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | US6984602 Olefin polymerization catalysts containing a pyrrole bisimine ligand |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006002117A1 Lactam tachykinin receptor antagonists |
| 01/05/2006 | WO2006000315A1 Pesticidal agents on the basis of 1- aryl- aminopyrrol |
| 01/05/2006 | US20060004220 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents |
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004020 Pyrrolidine derivatives as oxytocin antagonists |
| 01/05/2006 | CA2570995A1 Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/05/2006 | CA2570813A1 Lactam tachykinin receptor antagonists |